Grafa News and Videos — Page 88

GenusPlus Group (ASX:GNP) secured a design and construct contract valued at approximately $135 million from Atmos Renewables.

Washington H. Soul Pattinson (ASX:SOL) or Soul Patts boosted its post-tax net asset value by 31.4% to $14.5 billion for the 2026 financial year.

BHP (ASX:BHP) suspended all operational activities at its Escondida copper mine in Chile following the death of a worker during site maintenance.

Paradigm Biopharmaceuticals (ASX:PAR) has missed a key efficacy threshold in its Phase 3 trial for knee osteoarthritis.

The OECD downgraded Australia's 2027 GDP growth forecast to 1.7% as surging bond yields and commodity price shocks weigh on the outlook.

Novartis (NYSE:NVS) won a lawsuit in Manhattan federal court after a judge dismissed claims that the company improperly used an Entresto patent listing to delay generic competition.

Devon Energy (NYSE:DVN) received a letter from Toms Capital Management urging the company to explore strategic alternatives, including a potential sale of the entire company.

Bio-Techne (NASDAQ:TECH) shareholders approved the proposed acquisition by Merck KGaA, Darmstadt, Germany, at a special meeting held on September 23, 2026.

Immunovant (NASDAQ:IMVT) reported topline results from Period 1 of its proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.